Who owns Celldex Therapeutics?

Key details on Celldex Therapeutics (Ticker: CLDX)

Who owns Celldex Therapeutics?

Is CLDX a good stock to own? Find out who bought Celldex Therapeutics, who sold Celldex Therapeutics (CLDX) stock, and who holds a large position in Celldex Therapeutics.

Fund Name Number of Shares Share Valuation As Of
FMR 14.53M $404.85M March 31, 2015
OppenheimerFunds 9.13M $254.32M March 31, 2015
Franklin Resources 8.67M $241.72M March 31, 2015
Vanguard 6.09M $169.74M March 31, 2015
First Trust Advisors 4.74M $132.02M March 31, 2015
BlackRock Fund Advisors 3.72M $103.65M March 31, 2015
Jennison Associates 3.03M $39.24M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 2.99M $83.34M March 31, 2015
Columbia Wanger Asset Management 2.80M $78.06M March 31, 2015
LORD, ABBETT & CO 2.67M $48.72M Dec. 31, 2014
HealthCor Management 2.50M $8.88M June 30, 2011
SUSQUEHANNA INTERNATIONAL 2.49M $32.31M Sept. 30, 2014
STATE STREET CORPORATION 2.31M $64.41M March 31, 2015
Millennium Management 2.07M $57.70M March 31, 2015
OrbiMed Advisors 2.06M $37.64M Dec. 31, 2014
TimesSquare Capital Management 1.85M $51.43M March 31, 2015
BlackRock Advisors 1.83M $28.55M June 30, 2013
S.A.C. Capital Advisors 1.82M $32.14M March 31, 2014
First Eagle Investment Management 1.66M $8.62M June 30, 2012
Columbus Circle Investors 1.63M $29.71M Dec. 31, 2014
Wellington Management Company 1.62M $25.26M June 30, 2013
HealthCor Management 1.45M $22.63M June 30, 2013
Sectoral Asset Management 1.41M $24.90M March 31, 2014
ALLIANCEBERNSTEIN 1.40M $21.86M June 30, 2013
TSP Capital Management 1.38M $9.27M Dec. 31, 2012
Deutsche Bank Aktiengesellschaft 1.35M $37.67M March 31, 2015

Who sold Celldex Therapeutics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Ridgeback Capital Investments Dec. 31, 2012 3.80M $25.53M